Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)
Immune Ablation and Hematopoietic Stem Cell Transplantation in Patients With Autoimmune-Related Retinopathy and Optic Neuropathy (ARRON) Syndrome (Not Associated With Cancer)
Status: Archived
mi
from
Chicago, IL
Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)
Immune Ablation and Hematopoietic Stem Cell Transplantation in Patients With Autoimmune-Related Retinopathy and Optic Neuropathy (ARRON) Syndrome (Not Associated With Cancer)
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Autoimmune Dysregulation in Pigmentary Glaucoma
Autoimmune Dysregulation in Pigmentary Glaucoma
Status: Archived
mi
from
Madison, WI
Autoimmune Dysregulation in Pigmentary Glaucoma
Autoimmune Dysregulation in Pigmentary Glaucoma
Status: Archived
Updated: 1/1/1970
Dean Clinic
mi
from
Madison, WI
Phacoemulsification Sleeves
Determination of Surgical Efficacy and Most Efficient Surgical Parameters for Use With the 2.2, 2.8, and 3.0mm Phacoemulsification Sleeves Used With the Alcon Infinity 1.1mm ABS Flared Tip
Status: Archived
mi
from
Madison, WI
Phacoemulsification Sleeves
Determination of Surgical Efficacy and Most Efficient Surgical Parameters for Use With the 2.2, 2.8, and 3.0mm Phacoemulsification Sleeves Used With the Alcon Infinity 1.1mm ABS Flared Tip
Status: Archived
Updated: 1/1/1970
Dean Clinic
mi
from
Madison, WI
Tracking Optical Coherence Tomography
Tracking Optical Coherence Tomography
Status: Archived
mi
from
Pittsburgh, PA
Tracking Optical Coherence Tomography
Tracking Optical Coherence Tomography
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
mi
from
Pittsburgh, PA
Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
Status: Archived
mi
from
Louisville, KY
Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
Status: Archived
Updated: 1/1/1970
Retina Vitreous Resource Center
mi
from
Louisville, KY
One Hour Preoperative Gatifloxacin
One Hour Preoperative Gatifloxacin
Status: Archived
mi
from
Stanford, CA
One Hour Preoperative Gatifloxacin
One Hour Preoperative Gatifloxacin
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Intra Ocular Pressure During Robotic Prostatectomy
Intra Ocular Pressure During Robotic Prostatectomy
Status: Archived
mi
from
New York, NY
Intra Ocular Pressure During Robotic Prostatectomy
Intra Ocular Pressure During Robotic Prostatectomy
Status: Archived
Updated: 1/1/1970
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
A Prospective, Multicenter, Randomized Controlled Study of the Effect of Lotepredol Etabonate on The Initiation of Dry Eye Treatment With Topical Cyclosporine
Status: Archived
mi
from
Lynbrook, NY
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
A Prospective, Multicenter, Randomized Controlled Study of the Effect of Lotepredol Etabonate on The Initiation of Dry Eye Treatment With Topical Cyclosporine
Status: Archived
Updated: 1/1/1970
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series
To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series With Respect to Reliability, Reproducibility, Test Duration, Patient Preference, Technician Preference.
Status: Archived
mi
from
Fairfax, VA
To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series
To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series With Respect to Reliability, Reproducibility, Test Duration, Patient Preference, Technician Preference.
Status: Archived
Updated: 1/1/1970
Capital Eye Consultants
mi
from
Fairfax, VA
Identification of Key Blood Molecular Markers for Immunotherapy
Identification of Key Blood Molecular Markers for Immunotherapy
Status: Archived
mi
from
Stanford, CA
Identification of Key Blood Molecular Markers for Immunotherapy
Identification of Key Blood Molecular Markers for Immunotherapy
Status: Archived
Updated: 1/1/1970
Stanford University School of Medicine
mi
from
Stanford, CA
A Multi-Center Study of Reading Rehabilitation in Macular Disease
A Multi-Center Study of Reading Rehabilitation in Macular Disease
Status: Archived
mi
from
Chicago, IL
A Multi-Center Study of Reading Rehabilitation in Macular Disease
A Multi-Center Study of Reading Rehabilitation in Macular Disease
Status: Archived
Updated: 1/1/1970
Jesse Brown VAMC (WestSide Division)
mi
from
Chicago, IL
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.
Status: Archived
mi
from
Los Angeles, CA
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.
Status: Archived
Updated: 1/1/1970
Juels Stein Eye Institute
mi
from
Los Angeles, CA
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.
Status: Archived
mi
from
Palm Desert, CA
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.
Status: Archived
Updated: 1/1/1970
Southern California Desert Retina Consultants
mi
from
Palm Desert, CA
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.
Status: Archived
mi
from
Rapid City, SD
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.
Status: Archived
Updated: 1/1/1970
Black Hills Eye Institute
mi
from
Rapid City, SD
Pegaptanib Therapy in Uveitis
Evaluation of the Utility of Intravitreal Vascular Endothelial Growth Factor (VEGF) Blockade With Pegaptanib in Cystoid Macular Edema (CME) Associated With Non Infectious Intermediate and Panuveitis in an Open Label, Non Randomized, Uncontrolled Interventional Pilot Trial.
Status: Archived
mi
from
Winston-Salem, NC
Pegaptanib Therapy in Uveitis
Evaluation of the Utility of Intravitreal Vascular Endothelial Growth Factor (VEGF) Blockade With Pegaptanib in Cystoid Macular Edema (CME) Associated With Non Infectious Intermediate and Panuveitis in an Open Label, Non Randomized, Uncontrolled Interventional Pilot Trial.
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Partnership for Rapid Elimination of Trachoma
Research to Programs for Trachoma Elimination: Antibiotic Trial
Status: Archived
mi
from
San Francisco, CA
Partnership for Rapid Elimination of Trachoma
Research to Programs for Trachoma Elimination: Antibiotic Trial
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Partnership for Rapid Elimination of Trachoma
Research to Programs for Trachoma Elimination: Antibiotic Trial
Status: Archived
mi
from
Baltimore, MD
Partnership for Rapid Elimination of Trachoma
Research to Programs for Trachoma Elimination: Antibiotic Trial
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®
Status: Archived
mi
from
Lynbrook, NY
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®
Status: Archived
Updated: 1/1/1970
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
mi
from
Fort Worth, TX
Ciracadian Ocular Perfusion and Ocular Blood Flow
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Kynex Versus Refresh Plus Study in Subject With Dry Eye
The Effect of Kynex Versus Refresh Plus in Subjects With Mild to Moderate Dry Eye - A Parallel Group, Randomized, Masked Study
Status: Archived
mi
from
Fort Worth, TX
Kynex Versus Refresh Plus Study in Subject With Dry Eye
The Effect of Kynex Versus Refresh Plus in Subjects With Mild to Moderate Dry Eye - A Parallel Group, Randomized, Masked Study
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery
Effect of Perioperative Intravenous Lidocaine Administration or Epidural Anesthesia on Postoperative Outcomes in Complex Spine Surgery
Status: Archived
mi
from
Weston, FL
Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery
Effect of Perioperative Intravenous Lidocaine Administration or Epidural Anesthesia on Postoperative Outcomes in Complex Spine Surgery
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids Following a Periocular Steroid Injections in Patients on Steroid Sparing Agents or Low Dose Steroids
Status: Archived
mi
from
Salt Lake City, UT
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids Following a Periocular Steroid Injections in Patients on Steroid Sparing Agents or Low Dose Steroids
Status: Archived
Updated: 1/1/1970
John Moran Eye Center
mi
from
Salt Lake City, UT
mi
from
Irvine, CA
Study of T-PRED(TM) Compared to Pred Forte(R) II
Status: Archived
Updated: 1/1/1970
ISTA Pharmaceuticals, Inc.
mi
from
Irvine, CA
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
A Randomized, Parallel-Group, Placebo-Control, Double-Blind Trial Comparing the Efficacy and Safety of Nutritional Supplementation Containing Omega 3 Fatty Acids and Gamma Linoleic Acid, for Treatment of Keratoconjunctivitis Sicca in Post-Menopausal Females
Status: Archived
mi
from
Houston, TX
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
A Randomized, Parallel-Group, Placebo-Control, Double-Blind Trial Comparing the Efficacy and Safety of Nutritional Supplementation Containing Omega 3 Fatty Acids and Gamma Linoleic Acid, for Treatment of Keratoconjunctivitis Sicca in Post-Menopausal Females
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
A Randomized, Parallel-Group, Placebo-Control, Double-Blind Trial Comparing the Efficacy and Safety of Nutritional Supplementation Containing Omega 3 Fatty Acids and Gamma Linoleic Acid, for Treatment of Keratoconjunctivitis Sicca in Post-Menopausal Females
Status: Archived
mi
from
Norfolk, VA
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
A Randomized, Parallel-Group, Placebo-Control, Double-Blind Trial Comparing the Efficacy and Safety of Nutritional Supplementation Containing Omega 3 Fatty Acids and Gamma Linoleic Acid, for Treatment of Keratoconjunctivitis Sicca in Post-Menopausal Females
Status: Archived
Updated: 1/1/1970
Virginia Eye Consultants
mi
from
Norfolk, VA
Apremilast in the Treatment of Uveitis
An Open-label Trial to Assess the Efficacy and Safety of Apremilast in the Management of Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression.
Status: Archived
mi
from
Portland, OR
Apremilast in the Treatment of Uveitis
An Open-label Trial to Assess the Efficacy and Safety of Apremilast in the Management of Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression.
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
Comparison of the Effect of Fluticasone Furoate Nasal Spray Versus Placebo on Allergic Mediators in the Tears of Subjects With Tree or Grass Pollen Allergy
Status: Archived
mi
from
Chicago, IL
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
Comparison of the Effect of Fluticasone Furoate Nasal Spray Versus Placebo on Allergic Mediators in the Tears of Subjects With Tree or Grass Pollen Allergy
Status: Archived
Updated: 1/1/1970
Rush University Medical Center
mi
from
Chicago, IL
Effect of Different Concentrations of 1334H on Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Vehicle Controlled Evaluation of the of 1334H 0.15%, 0.3%, and 0.45% Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Status: Archived
mi
from
Andover, MA
Effect of Different Concentrations of 1334H on Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Vehicle Controlled Evaluation of the of 1334H 0.15%, 0.3%, and 0.45% Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Status: Archived
Updated: 1/1/1970
ORA Inc
mi
from
Andover, MA
SENSIMED Triggerfish Safety and Tolerability
Evaluation of SENSIMED Triggerfish Safety and Tolerability in Glaucoma Patients and Glaucoma Suspects
Status: Archived
mi
from
San Francisco, CA
SENSIMED Triggerfish Safety and Tolerability
Evaluation of SENSIMED Triggerfish Safety and Tolerability in Glaucoma Patients and Glaucoma Suspects
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
mi
from
Fort Worth, TX
AL-54478 Proof of Concept Study
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
mi
from
Fort Worth, TX
Alcon Call Center
mi
from
Fort Worth, TX
A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
Status: Archived
mi
from
Ft Worth, TX
A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
Status: Archived
Updated: 1/1/1970
Anna Martin
mi
from
Ft Worth, TX
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Treatment of Ocular Inflammation Associated With Cataract Surgery
Status: Archived
mi
from
Independence, MO
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Treatment of Ocular Inflammation Associated With Cataract Surgery
Status: Archived
Updated: 1/1/1970
Discover Vision Centers
mi
from
Independence, MO
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Louisville, KY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Taustine Eye Center
mi
from
Louisville, KY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
St Louis, MO
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Comprehensive Eye Care
mi
from
St Louis, MO
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Rochester, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Rochester Ophthalmology Group
mi
from
Rochester, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Slingerlands, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Glaucoma Consultants of the Capital Region
mi
from
Slingerlands, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Charlotte, NC
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Tulsa, OK
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
The Eye Institute
mi
from
Tulsa, OK
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Philadelphia, PA
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Wills Eye Institute
mi
from
Philadelphia, PA
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
mi
from
Rapid City, SD
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Black Hills Eye Institute
mi
from
Rapid City, SD
Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
Comparison of Porcine Submucosal Tissue Patch Graft (KeraSys) Versus Processed Pericardium Patch Graft (Tutoplast) in Glaucoma Drainage Implant Surgery Using a Molteno 3 Shunt
Status: Archived
mi
from
Philadelphia, PA
Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
Comparison of Porcine Submucosal Tissue Patch Graft (KeraSys) Versus Processed Pericardium Patch Graft (Tutoplast) in Glaucoma Drainage Implant Surgery Using a Molteno 3 Shunt
Status: Archived
Updated: 1/1/1970
Wills Eye Institute
mi
from
Philadelphia, PA
A Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses
A Randomized, Pilot Study, Subject Masked Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses (IOLs)
Status: Archived
mi
from
Fort Worth, TX
A Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses
A Randomized, Pilot Study, Subject Masked Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses (IOLs)
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Status: Archived
mi
from
Boynton Beach, FL
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Status: Archived
Updated: 1/1/1970
Florida Eye Microsurgical Institute
mi
from
Boynton Beach, FL
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Status: Archived
mi
from
Maitland, FL
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
Status: Archived
Updated: 1/1/1970
Eye Physicians of Central Florida
mi
from
Maitland, FL
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
mi
from
Rochester, NY
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
Updated: 1/1/1970
Bausch & Lomb
mi
from
Rochester, NY
Divided Dose of Travatan
Status: Archived
mi
from
Fort Worth, TX
Divided Dose of Travatan
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX